arrow_back Back to Course List
swap_horiz Are you a Pharmacist? View the Pharmacist version
description Monograph

Pharmacologic Approaches to Diabetes Treatment: Oral Medications

Target Audience: Pharmacy Tech

star star star star star_outline 4.4/5 based on 108 ratings
schedule 1.00 Contact Hours (0.10 CEUs)
category Disease State Management/Drug Therapy
local_activity Knowledge

Course Overview

The management of Type 2 diabetes mellitus (T2DM) involves a holistic, patient-centered approach that encompasses lifestyle modifications and the use of pharmacologic therapies. While current American Diabetes Association (ADA) Standards of Care 2023 guidelines highlight the benefits of injectable agents for reaching glycemic and weight loss goals and reducing cardiorenal risks, oral antidiabetic (OAD) medications still have important roles to play in the care plans of many patients. Numerous classes of OADs are available, each with its unique mechanism of action, efficacy, and safety profile. This course will compare available oral medications for diabetes with a discussion of mechanisms of action, dosing, side effects, and contraindications. The suggested place of these various medications within a therapeutic regimen will be discussed in the context of the updated American Diabetes Association Standards of Care in Diabetes 2023 guidelines.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Compare and contrast the mechanisms of action of available oral diabetes medications
  • Describe the side effects and contraindications of oral diabetes medications
  • Identify when to utilize oral diabetes medications within a therapeutic regimen for patients with Type 2 diabetes mellitus
  • Recall patient counseling points related to the use of oral diabetes medications

Faculty

Authors & Activity Planners
L. Austin Fredrickson, MD, FACP
View Bio +
Dr. Fredrickson is an assistant professor of internal medicine at Northeast Ohio Medical University, where he serves as core faculty and teaches diagnostics, therapeutics, clinical skills, and health humanities. He is board-certified in general internal medicine and practices rural primary care.

I. Introduction

II. Oral Antidiabetic Medications

1. Metformin
2. Sulfonylureas
3. Thiazolidinediones
4. DPP4-Inhibitors
5. SGLT-2 Inhibitors
6. Other Oral Agents

III. Choice of Glucose-Lowering Therapy

1. Combination Therapy
2. Glycemic Control
3. Weight Effects
4. Hypoglycemia
5. Cardiovascular and Renal Protection
6. Cost

IV. Summary

From June 24, 2023 through June 24, 2026, participants must:

  1. Read the "learning objectives" and "author and planning team disclosures"
  2. Study the section entitled "educational activity"
  3. Complete the Course Test and Evaluation form. The Course Test will be graded automatically. Following successful completion of the Course Test with a score of 70% or higher, a statement of participation will be made available immediately. (No partial credit will be given.)

Credit for this course will be automatically uploaded to CPE Monitor®.

Faculty Planner Disclosure

The management of Type 2 diabetes mellitus (T2DM) involves a holistic, patient-centered approach that encompasses lifestyle modifications and the use of pharmacologic therapies. While current American Diabetes Association (ADA) Standards of Care 2023 guidelines highlight the benefits of injectable agents for reaching glycemic and weight loss goals and reducing cardiorenal risks, oral antidiabetic (OAD) medications still have important roles to play in the care plans of many patients. Numerous classes of OADs are available, each with its unique mechanism of action, efficacy, and safety profile. This course will compare available oral medications for diabetes with a discussion of mechanisms of action, dosing, side effects, and contraindications. The suggested place of these various medications within a therapeutic regimen will be discussed in the context of the updated American Diabetes Association Standards of Care in Diabetes 2023 guidelines.

Unlabeled Use Disclosure

The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.

Please ensure the device you plan to use meets these requirements:

  • Operating System: Windows 7, 8, 10, or 11 / Mac OS X 10.9 or later / iOS / Android
  • Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
  • A connection to the internet

Accreditation

In support of improving patient care, RxCE.com is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PTCB Recognition

RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".